ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Preventing of Rejection of Vascularized Composite Allografts by Targeting T Cell Metabolism.

    B. Oh,1 C. Cheng,2 G. Furtmüller,1 W. Lee,1 J. Powell,2 G. Brandacher.1

    1Plastic and Reconstructive Surgery, Johns Hopkins University School of Medicine, Baltimore, MD; 2Oncology, Johns Hopkins University School of Medicine, Baltimore, MD

    [Background] Upon antigen recognition and co-stimulation, T lymphocytes upregulate the metabolic machinery necessary to proliferate and sustain effector function. This metabolic reprogramming in T cells…
  • 2017 American Transplant Congress

    Unintended Consequence of the New Kidney Allocation System – Disproportionate Allocation of High Quality Kidneys to Highly Sensitized Recipients.

    B. Murthy, N. Galvan, J. Moffett, C. O'Mahony, J. Goss, A. Rana.

    Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX

    Purpose: We hypothesize that improving access to highly sensitized candidates in new KAS would compromise the prime objective of matching the best kidney allografts and…
  • 2017 American Transplant Congress

    Short-Term Adverse Effects of Early Borderline Changes in Renal Allograft Biopsies.

    S. Bhusal, P. Sood, A. Cherukuri, C. Wu, C. Puttarajappa, W. Hoffman, P. Randhawa, A. Tevar, N. Shah, S. Hariharan, R. Mehta.

    Department of Medicine and Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA

    Background: The short and long-term impact of borderline changes noted on renal allograft biopsies remains unclear.Methods: A total of 379 patients underwent renal transplantation at…
  • 2017 American Transplant Congress

    Does Cirrhosis Regress in HCV Liver Transplant Recipients Achieving Sustained Virologic Response in the Era of Direct-Acting Antiviral Agents?

    J. Putra,1 T. Schiano,2 M. Fiel.1

    1Pathology, Icahn School of Medicine at Mount Sinai, New York, NY; 2Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY

    Background: Treatment with direct-acting antiviral agents (DAAs) in HCV patients is associated with high sustained virologic response (SVR) rates. It is hoped that cirrhosis regresses…
  • 2017 American Transplant Congress

    Experience with the Bacterial Enzyme IdeS (IgG Endopeptidase) for Desensitization of Highly-HLA Sensitized (HS) Kidney Allograft Recipients.

    S. Jordan,1 J. Choi,1 C. Kjellman,2 L. Winstedt,2 X. Zhang,4 S. Louie,1 A. Kang,1 M. Haas,3 A. Vo.1

    1Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA; 2Hansa Medical, Lund, Sweden; 3Dept of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA; 4HLA, Cedars-Sinai Medical Center, Los Angeles, CA

    Donor specific antibodies (DSA) create an impenetrable immunologic barrier to transplantation. Current rx aimed at modification of DSAs are not effective in the most HS…
  • 2017 American Transplant Congress

    Tracking the In Vitro Phenotype and Proliferative Capacity of CD57+ CD4 T Cells.

    J. Espinosa,1 J. Lockley,1 F. Shaw,1 R. Osborne,1 M. Joshi,1 T. Woody,1 M. Ellis,1 B. Hollister,1 J. Cheeseman,1 R. Townsend,2 A. Kirk.1

    1Duke University, Durham; 2Bristol-Meyers Squibb, Princeton

    CD57+PD1- CD4 T cells are primed effectors with increased expression of adhesion molecules capable of infiltrating allografts and mediating belatacept-resistant rejection (BRR). Whether CD57 is…
  • 2017 American Transplant Congress

    Dominant Role of Clonal Deletion in Achieving Immune Tolerance After Unrelated Cord Blood Transplantation.

    P. Szabolcs,1,2 X. Chen,1 M. Hill.1

    1BMT and Cell Therapy, Children Hospital of Pittsburgh UPMC, Pittsburgh, PA; 2Immunology, University of Pittsburgh, Pittsburgh, PA

    The mechanism of immune tolerance after successful hematopoietic stem cell transplantation is not fully understood. Both central (clonal deletion) and peripheral (anergy, Treg, Tr1) mechanisms…
  • 2017 American Transplant Congress

    Expression of Injury and Repair Genes in Ex Vivo Perfused Swing Lung Transplants.

    P. Dromparis,1 S. Wagner,1 N. Aboelnaz,2 J. Luc,2 D. Freed,2 J. Nagendran,2 M. Mengel,1 B. Adam.1

    1Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada; 2Surgery (Cardiac Surgery), University of Alberta, Edmonton, Canada

    Due to acute lung injury (ALI), only 20% of donated lungs are suitable for transplant and of those, 25% develop primary graft dysfunction. Ex vivo…
  • 2017 American Transplant Congress

    Hepatitis E Virus-Associated Cryoglobulinemia in Solid-Organ-Transplant Recipients: A Prospective Study.

    O. Marion,1 F. Abravanel,2 L. Esposito,1 S. Lhomme,2 A. Del Bello,1 J. Izopet,2 N. Kamar.1

    1Nephrology and Organ Transplant Unit, CHU Rangueil, Toulouse, France; 2Laboratory of Virology, CHU Purpan, Toulouse, France

    Hepatitis E virus (HEV) is responsible for acute and chronic autochthonous hepatitis in developed countries, particularly in Western Europe. Conversely to hepatitis B or C,…
  • 2017 American Transplant Congress

    Factors Predicting 30-Day Hospital Readmission After Kidney Transplant.

    J. Ostrem, M. Brokhof, N. Kenyon, E. Hollinger, S. Jensik, O. Olaitan, M. Hertl, N. Alvey.

    Rush University Medical Center, Chicago, IL

    Background: Hospital readmissions after kidney transplant have been associated with increased morbidity, mortality, decreased quality of life, and increased healthcare costs. The objective of this…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences